Chevy Chase Trust
WST icon

Chevy Chase Trust’s West Pharmaceutical WST Stock Holding History

Chevy Chase Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Sell
34,114
-1,329
-4% -$406K 0.03% 373
2026
Q1 		$8.88M Sell
35,443
-1,032
-3% -$257K 0.03% 426
2025
Q4 		$10M Sell
36,475
-223
-0.6% -$61K 0.03% 412
2025
Q3 		$9.63M Sell
36,698
-1,250
-3% -$304K 0.03% 413
2025
Q2 		$8.3M Sell
37,948
-34
-0.1% -$7.27K 0.02% 436
2025
Q1 		$8.5M Sell
37,982
-318
-0.8% -$87.6K 0.03% 429
2024
Q4 		$12.5M Sell
38,300
-890
-2% -$280K 0.04% 358
2024
Q3 		$11.8M Sell
39,190
-627
-2% -$192K 0.04% 377
2024
Q2 		$13.1M Sell
39,817
-1,158
-3% -$409K 0.04% 335
2024
Q1 		$16.2M Sell
40,975
-356
-0.9% -$132K 0.05% 301
2023
Q4 		$14.6M Sell
41,331
-187
-0.5% -$66.2K 0.05% 309
2023
Q3 		$15.6M Sell
41,518
-1,194
-3% -$462K 0.06% 279
2023
Q2 		$16.3M Sell
42,712
-311
-0.7% -$111K 0.06% 284
2023
Q1 		$14.9M Buy
43,023
+443
+1% +$129K 0.06% 300
2022
Q4 		$10M Sell
42,580
-2,635
-6% -$624K 0.04% 369
2022
Q3 		$11.1M Buy
45,215
+480
+1% +$146K 0.05% 347
2022
Q2 		$13.5M Buy
44,735
+186
+0.4% +$60.5K 0.06% 307
2022
Q1 		$18.3M Buy
44,549
+122
+0.3% +$47.8K 0.06% 280
2021
Q4 		$20.8M Sell
44,427
-995
-2% -$428K 0.07% 264
2021
Q3 		$19.3M Sell
45,422
-1,620
-3% -$683K 0.07% 261
2021
Q2 		$16.9M Sell
47,042
-2,692
-5% -$889K 0.06% 299
2021
Q1 		$14M Sell
49,734
-3,482
-7% -$997K 0.05% 340
2020
Q4 		$15.1M Sell
53,216
-1,538
-3% -$432K 0.05% 312
2020
Q3 		$15.1M Sell
54,754
-4,473
-8% -$1.18M 0.06% 288
2020
Q2 		$13.5M Buy
+59,227
New +$11.6M 0.05% 312

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Chevy Chase Trust's WST Position: Q2 2026 in Review

Chevy Chase Trust reduced its West Pharmaceutical (WST) stake by 3.7% in Q2 2026, selling an estimated $406K and leaving 34,114 shares worth $12.2M. The position accounts for 0.03% of the portfolio, ranked #373.

Chevy Chase Trust first reported a position in WST in Q2 2020 and has held it in 25 quarters since. The position peaked at $20.8M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Chevy Chase Trust held 34,114 shares of West Pharmaceutical worth $12.2M as of Q2 2026.
  • Chevy Chase Trust sold 1,329 West Pharmaceutical shares in Q2 2026, an estimated $406K.
  • West Pharmaceutical made up 0.03% of Chevy Chase Trust's portfolio in Q2 2026, its #373 holding.
  • Chevy Chase Trust first reported a position in West Pharmaceutical in Q2 2020 and has held it in 25 quarters since.
  • Chevy Chase Trust's West Pharmaceutical position peaked at $20.8M in Q4 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Chevy Chase Trust's 13F filing for Q2 2026, filed 14 Aug 2026.